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ABSTRACT 
Polyspecific antiserum against total rat serum proteins was used to develop 
specific and sensitive radioimmunoassays for fetuin and bikunin, two minor 
protein components of rat plasma. The radioimmunoassays proved to be highly 
useful to trace bikunin and fetuin in the course of developing isolation proce- 
dures, since neither specific functional assays nor monospecific antisera were 
available. The two examples demonstrate that, in general, it will be possible to 
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develop a specific and sensitive radioimmunoassay with antiserum raised against 
a crude antigen preparation, such as a body fluid or a tissue extract, provided 
that a minute amount of pure antigen is available for preparing the radioiodina- 
ted antigen. 
INTRODUCTION 
Radioimmunoassays have been widely used for the specific determination 
of many protein and other antigens. They are based on the competition of radio- 
actively labeled and unlabeled antigen for binding to a specific antibody . The 
presence of an antigen in a sample is recognized by the partial inhibition of the 
binding of radioactively labeled antigen to the antibody. Generally one uses 
monospecific antibodies in radioimmunoassays, but from a theoretical point of 
view this is unnecessary, since other antibodies present in the incubation mixture 
do not influence the reaction between the antigen to be determined and its cog- 
nate antibody. Therefore, antiserum against a crude antigen may be employed in 
radioimmunoassays provided that pure antigen is used as a tracer. 
1 
We would like to direct attention to this special aspect of radioimmunoas- 
says of which researchers experienced in immunoassay techniques will be 
aware, but which is, nevertheless, often overlooked. Making use of this aspect 
can be of considerable practical value for example when a specific assay for a 
protein is needed, but the amount of available antigen is too low, or time too 
short for antiserum production: a radioimmunoassay may be set up using an 
antiserum raised against a crude preparation of the protein or even against a raw 
extract of the tissue which contains the protein. Here we report radioimmunoas- 
says for the determination of two minor components of rat plasma, fetuin 
and bikunin 
2 
, by using purified proteins for tracer preparation and as stan- 
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dards, and a commercially available antiserum against whole rat serum protein. 
Both assays were used for developing and optimizing the isolation procedures. 
METHODS 
N a W  IMS30, Amersham Buchler, Braunschweig, Germany; Tween 20 
(37470), polyethylene glycol 6OOO (33 133, thimerosal (77018), bovine serum 
albumin (1 1930), rabbit gamma-globulin (22540): Serva, Heidelberg, Germany: 
PD-10 column: Pharmabia; rabbit anti-rat serum: Z 178, Dakopats, Denmark 
precipitating antiserum: donkey anti-rabbit immunoglobulin G antiserum, A- 
PPT1, IDS, 5 n e  & War, England; chloramine T (2426) and all other reagents 
(analytical grade): E. Merck, Darmstadt, Germany; RIA tubes (73.1055): Sar- 
stedt, Niimbrecht, Germany; Gamma-counter: Hydragamma 16, Zinsser, Frank- 
furt, Germany. 
Rat bikunin and fetuin , from rat plasma were available in amounts 
of about 200 pg. Purity of the proteins was verified by N-terminal amino acid 
sequencing using a gas phase sequencer (Applied Biosystems, Model 477A) 
c o ~ e ~ t e d  to an on-line HPLC 120A system for identification of the phenylthb 
hydantoin derivatives. Protein concentrations of antigen stock solutions were 
determined by amino acid analysis. 
Bufers. Buffer A: 15 mM NaH,PO.,, 0.15 M NaC1, pH 7.4; buffer B: 
buffer A containing in addition 200 mg thimerosal/l, 2.0 g bovine serum albu- 
min/l, 0.01 M EDTA; buffer C: same as buffer B but containing 40 g bovine 
serum albumin/l; buffer D: buffer B containing in addition 60 g polyethylene 
glycol m/1. 
lodinarion. All reagents were dissolved in buffer A. 10 1 protein solution 
(containing 2 pg rat fetuin or 1.5 pg rat bikunin), 10 pl (0.33 mCI = 12.3 
9
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MBq) NalzI and 10 pl (30 pg) chloramine T were mixed in a glass vial with 
coNcally shaped bottom. After 5-10 s 20 pl of a solution of sodiumdisulfite (3 
mg/ml) was added. The mixture was immediately transferred to a PD-10 column 
which had been pretreated with 3 ml buffer C and equilibrated with 30 ml of 
buffer A. The vial was rinsed once with 50 p1 of a potassium iodide solution, 10 
g/l. The column was eluted with buffer A and 0.5 ml fractions were collected 
into polypropylene tubes containing 50 pl buffer C. The 2-3 fractions with the 
highest radioactivity of the first radioactivity peak were pooled and diluted with 
buffer B to approximately 500,000 counts/min/ml and rabbit gamma-globulin, 
70 mg/l, was added. The calculated specific radioactivities were 14-20 pCi/pg 
for fetuin and 60-1 10 pCi/pg for bikunin. 
Tifrufion Curves. Appropriate dilutions of the antiserum to rat serum were 
determined by setting up titration curves. 100 pl buffer B, 50 p1 anti-rat serum 
(dilutions from 1:400 to 1:64,000 in buffer C), 50 pl of labeled antigen (25,000 
counts/min) were mixed and incubated for 14-18 h at room temperature. Then 
50 p1 of precipitating antiserum (dilution 1:32 in buffer C, optimized for this 
system following the manufacturer's instruction) and 250 pl of buffer D were 
added. The tubes were centrifuged immediately for 15 min at about 4 000 g. 
The supernatant was aspirated, the pellet washed once by adding 250 pl buffer 
D, centrifugation and aspiration of the supernatant. Then the radioactivity of the 
precipitate was measured. 
Radioimmunoassay procedure. 50 pl each of buffer B, sample (unknown 
or standard, 0.4-200 pg/l, in buffer B), labeled antigen, and diluted rabbit anti- 
serum to rat serum were mixed in RIA tubes and incubated for 16-24 h at room 
temperature. Precipitation by the second antibody and counting was performed 
as described above. The results were evaluated on-line by the spline approxima- 
tion method using the program RIALOG I1 (Zinsser, Frankfurt, Germany). 
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RESULTS AND DISCUSS ION 
Recently it was reported that rat plasma contained an inhibitor to the insu- 
5 296 which turned out to be identical with rat fetuin 
In order to perform studies on the function of fetuin we set out to isolate it 
from rat plasma, but neither an assay procedure nor a specific antibody were 
accessible to us. Therefore, since a small amount of fetuin was available, we 
investigated whether a commercial antiserum against whole rat serum could be 
utilized to develop a radioimmunoassay for rat fetuin. Later, the suitability of 
using such a plyspecific antiserum in radioimmunoassays was further corro- 
borated by setting up a radioimmunoassay for rat bikunin employing the same 
antiserum as for the fetuin assay (bikunin is the inhibitorily active subunit of 
inter-a-trypsin inhibitor . 
lin receptor tyrosine kinase 
3 
The antigens were radioiodinated by the chloramine T method ('7) which is 
generally applicable for iodination of proteins containing tyrosine and/or histi- 
dine residues, is easy to perform and requires only minute quantities of protein; 
in our experiments we used 1-2 pg for one iodination. 
Fig. 1 shows titration curves for radioiodinated rat fetuin and rat bikunin. 
The maximum percentage of radioactive antigen bound by the antibody varied 
for different iodinations, it was about 15-38 46 for fetuin and 19-51 96 for biku- 
nin (five iodinations each). This binding is relatively low and may be due to 
alterations of molecular structures during iodination. Nevertheless, all of these 
tracer preparations were used in the radioimmunoassays, some of them for up to 
three months. For the radioimmunoassays, antiserum dilutions were chosen from 
the titration curves which caused a binding of radioactivity of about two thirds 
of maximum binding. As the radioimmunoassays were to be used mainly during 
developing isolation procedures of the two proteins and not for routine quantifi- 
2592 FINK ET AL. 
1: lOO 1:1000 1:10000 1:100000 
Antiserum Dilution 
FIG. 1. Titration curves of rat bikunin and fetuin. Dilutions of antiserum to rat 
serum protein were incubated with radioiodinated rat bikunin (-) and fetuin 
(---), respectively. Percentage of bound radioactivity was calculated by 100(B- 
N/T-N); B: bound radioactivity, T total radioactivity, N: bound radioactivity in 
the absence of antiserum. 
cation of the antigens, no effort was put into validating the assays in respect of, 
for example recovery of added antigen or parallelity of dose-response curves of 
serial dilutions of rat plasma and standard curves. 
The calibration curves of Fig. 2 show that rat bikunin and fetuin can be 
reliably determined in the ranges of 0.7-70 pg/1 and 3.0-150 pg/l (corresponding 
to 10-90 I of bound radioactivity). Both radioimmunoassays were utilized for 
developing procedures for the isolation of the two proteins from rat plasma 
(publications in preparation). 
The concentrations in several pools of rat plasma as determined by the 
radioimmunoassays were for bikunin 40-80 mg/l and for fetuin 135-320 mg/l. 
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FIG. 2. Standard curves of the radioimmunoassays for rat bikunin and fetuin. 
Increasing amounts of bikunin (-) and fetuin (---) were incubated in the pre- 
sence of a constant amount of labeled antigen with a constant dilution of antiser- 
um to rat serum protein. Percentage of bound radioactivity was calculated by 
lOO(B-N/$-N); B: bound radioactivity, $: bound radioactivity in the absence 
of unlabeled antigen, N: bound radioactivity in the absence of antiserum. 
These low concentrations, corresponding to about 0.06-0.11 46 and 0.2-0.5 % 
of total rat serum proteins to which the antiserum had been raised, demonstrate 
convincingly that immunization may be performed with extremely crude antigen 
preparations containing only traces of the particular antigen and, still, antisera 
can be obtained highly suitable for setting up sensitive radioimmunoassays. 
Generally, it will be sufficient to use all of the protein of biological fluids or 
tissue extracts for immunization, or, if the fraction of the antigen is too low, a 
partially purified protein preparation. 
Polyspecific antisera must be used with caution because the requirement 
for monospecificity in the radioimmunoassay cannot be guaranteed. For p ly-  
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specific antisera, the absence of crossreacting proteins in samples which have to 
be analysed, and which could compete in the radioimmunoassay, cannot be 
verified by techniques like Ouchterlony or immunoblot analysis, as it is possible 
for monospecific antiserum. The use of antisera raised against crude antigens 
will be of high value mainly in cases where monospecific or monoclonal antibo- 
dies are not available. 
In comparison to enzyme immunoassays, the radioimmunoassay is super- 
ior because of the fact that extremely low quantities of labeled antigen can be 
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